A Single Center, Open-label Trial of Isavuconazole Prophylaxis Against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Latest Information Update: 18 Nov 2021
At a glance
- Drugs Isavuconazonium (Primary) ; Isavuconazonium (Primary) ; Micafungin
- Indications Mycoses
- Focus Therapeutic Use
- 15 Nov 2021 Status changed from active, no longer recruiting to completed.
- 09 Aug 2021 Planned End Date changed from 1 May 2021 to 1 May 2022.
- 03 Jun 2020 Planned End Date changed from 1 May 2020 to 1 May 2021.